ID

35260

Descripción

Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults; ODM derived from: https://clinicaltrials.gov/show/NCT02493855

Link

https://clinicaltrials.gov/show/NCT02493855

Palabras clave

Versiones (1)
  1. 25/2/19 25/2/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

25 de febrero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Chronic Hepatitis C NCT02493855

Inglés

Eligibility Chronic Hepatitis C NCT02493855

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. screening laboratory result indicating hcv genotype 1 (gt1) a infection.
Descripción

Hepatitis C Genotype Laboratory test result

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019196
UMLS CUI [1,2]
C0017431
UMLS CUI [1,3]
C0587081
2. chronic hcv infection.
Descripción

Hepatitis C, Chronic

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0524910
3. subjects must be non-cirrhotic.
Descripción

Study Subject Non-cirrhotic

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0681850
UMLS CUI [1,2]
C0439687
4. subjects must be able to understand and adhere to the study visit schedule and all protocol requirements as well as voluntarily sign and date an institutional review board (irb) approved informed consent.
Descripción

Protocol Compliance | Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0525058
UMLS CUI [2]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. women who are pregnant or breastfeeding.
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
2. positive test result for hepatitis b surface antigen (hbsag) or anti-human immunodeficiency virus antibody (hiv ab) positive immunoassay.
Descripción

Hepatitis B surface antigen positive Immunoassay | HIV antibody positive Immunoassay

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0149709
UMLS CUI [1,2]
C0020980
UMLS CUI [2,1]
C0920548
UMLS CUI [2,2]
C0020980
3. clinically significant abnormalities or co-morbidities, other than hcv infection, that make the subject unsuitable for this study or treatment.
Descripción

Abnormality Study Subject Participation Status Inappropriate | Comorbidity Study Subject Participation Status Inappropriate | Exception Hepatitis C

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1704258
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C1548788
UMLS CUI [2,1]
C0009488
UMLS CUI [2,2]
C2348568
UMLS CUI [2,3]
C1548788
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0019196
4. current enrollment in another interventional clinical study. previous use of any hcv treatments including pegylated interferon (pegifn), ribavirin, or any direct acting antiviral agent, either investigational or approved, for hcv including protease inhibitors, nucleoside or non-nucleoside polymerase inhibitors, or ns5a inhibitors.
Descripción

Study Subject Participation Status | Interventional Study | Therapeutic procedure Hepatitis C virus | PEGINTERFERON | Ribavirin | Antiviral Agents Investigational Hepatitis C virus | Antiviral Agents Hepatitis C virus | Protease Inhibitors | Other Coding | Hepatitis C Virus NS5A Inhibitor

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C3274035
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C0220847
UMLS CUI [4]
C0982327
UMLS CUI [5]
C0035525
UMLS CUI [6,1]
C0003451
UMLS CUI [6,2]
C1517586
UMLS CUI [6,3]
C0220847
UMLS CUI [7,1]
C0003451
UMLS CUI [7,2]
C0220847
UMLS CUI [8]
C0033607
UMLS CUI [9]
C3846158
UMLS CUI [10]
C3883357
5. history or solid organ transplant.
Descripción

Solid organ transplant

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0730400
6. screening laboratory analysis that shows abnormal results.
Descripción

Laboratory test result abnormal

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0438215
Volver a la parte superior de la página

Similar models

Eligibility Chronic Hepatitis C NCT02493855

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Hepatitis C Genotype Laboratory test result
Item
1. screening laboratory result indicating hcv genotype 1 (gt1) a infection.
boolean
C0019196 (UMLS CUI [1,1])
C0017431 (UMLS CUI [1,2])
C0587081 (UMLS CUI [1,3])
Hepatitis C, Chronic
Item
2. chronic hcv infection.
boolean
C0524910 (UMLS CUI [1])
Study Subject Non-cirrhotic
Item
3. subjects must be non-cirrhotic.
boolean
C0681850 (UMLS CUI [1,1])
C0439687 (UMLS CUI [1,2])
Protocol Compliance | Informed Consent
Item
4. subjects must be able to understand and adhere to the study visit schedule and all protocol requirements as well as voluntarily sign and date an institutional review board (irb) approved informed consent.
boolean
C0525058 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
1. women who are pregnant or breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Hepatitis B surface antigen positive Immunoassay | HIV antibody positive Immunoassay
Item
2. positive test result for hepatitis b surface antigen (hbsag) or anti-human immunodeficiency virus antibody (hiv ab) positive immunoassay.
boolean
C0149709 (UMLS CUI [1,1])
C0020980 (UMLS CUI [1,2])
C0920548 (UMLS CUI [2,1])
C0020980 (UMLS CUI [2,2])
Abnormality Study Subject Participation Status Inappropriate | Comorbidity Study Subject Participation Status Inappropriate | Exception Hepatitis C
Item
3. clinically significant abnormalities or co-morbidities, other than hcv infection, that make the subject unsuitable for this study or treatment.
boolean
C1704258 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C1548788 (UMLS CUI [1,3])
C0009488 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C1548788 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0019196 (UMLS CUI [3,2])
Study Subject Participation Status | Interventional Study | Therapeutic procedure Hepatitis C virus | PEGINTERFERON | Ribavirin | Antiviral Agents Investigational Hepatitis C virus | Antiviral Agents Hepatitis C virus | Protease Inhibitors | Other Coding | Hepatitis C Virus NS5A Inhibitor
Item
4. current enrollment in another interventional clinical study. previous use of any hcv treatments including pegylated interferon (pegifn), ribavirin, or any direct acting antiviral agent, either investigational or approved, for hcv including protease inhibitors, nucleoside or non-nucleoside polymerase inhibitors, or ns5a inhibitors.
boolean
C2348568 (UMLS CUI [1])
C3274035 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C0220847 (UMLS CUI [3,2])
C0982327 (UMLS CUI [4])
C0035525 (UMLS CUI [5])
C0003451 (UMLS CUI [6,1])
C1517586 (UMLS CUI [6,2])
C0220847 (UMLS CUI [6,3])
C0003451 (UMLS CUI [7,1])
C0220847 (UMLS CUI [7,2])
C0033607 (UMLS CUI [8])
C3846158 (UMLS CUI [9])
C3883357 (UMLS CUI [10])
Solid organ transplant
Item
5. history or solid organ transplant.
boolean
C0730400 (UMLS CUI [1])
Laboratory test result abnormal
Item
6. screening laboratory analysis that shows abnormal results.
boolean
C0438215 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial